Virology Journal | |
The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus | |
Siddharth Balachandran1  Richard A Katz1  Anna Marie Skalka1  Shoko Nogusa1  Natalia Shalginskikh1  Kelsey A Haugh1  | |
[1] Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Room 422 Reimann Building, 333 Cottman Ave., 19111 Philadelphia, PA, USA | |
关键词: Innate immunity; Avian sarcoma virus; Interferon; Daxx; | |
Others : 804053 DOI : 10.1186/1743-422X-11-100 |
|
received in 2014-02-03, accepted in 2014-05-23, 发布年份 2014 | |
【 摘 要 】
Background
The antiviral protein Daxx acts as a restriction factor of avian sarcoma virus (ASV; Retroviridae) in mammalian cells by promoting epigenetic silencing of integrated proviral DNA. Although Daxx is encoded by a type I (α/β) interferon-stimulated gene, the requirement for Daxx in the interferon anti-retroviral response has not been elucidated. In this report, we describe the results of experiments designed to investigate the role of Daxx in the type I interferon-induced anti-ASV response.
Findings
Using an ASV reporter system, we show that type I interferons are potent inhibitors of ASV replication. We demonstrate that, while Daxx is necessary to silence ASV gene expression in the absence of interferons, type I interferons are fully-capable of inducing an antiviral state in the absence of Daxx.
Conclusions
These results provide evidence that Daxx is not essential for the anti-ASV interferon response in mammalian cells, and that interferons deploy multiple, redundant antiviral mechanisms to protect cells from ASV.
【 授权许可】
2014 Haugh et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140708052921224.pdf | 2690KB | download | |
Figure 4. | 94KB | Image | download |
Figure 3. | 44KB | Image | download |
Figure 2. | 61KB | Image | download |
Figure 1. | 91KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
Figure 4.
【 参考文献 】
- [1]Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997, 89:1067-1076.
- [2]Greger JG, Katz RA, Ishov AM, Maul GG, Skalka AM: The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol 2005, 79:4610-4618.
- [3]Shalginskikh N, Poleshko A, Skalka AM, Katz RA: Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx. J Virol 2013, 87:2137-2150.
- [4]Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386.
- [5]Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD: How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264.
- [6]Schaefer-Klein J, Givol I, Barsov EV, Whitcomb JM, VanBrocklin M, Foster DN, Federspiel MJ, Hughes SH: The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 1998, 248:305-311.
- [7]Balachandran S, Thomas E, Barber GN: A FADD-dependent innate immune mechanism in mammalian cells. Nature 2004, 432:401-405.
- [8]Fernandez M, Porosnicu M, Markovic D, Barber GN: Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol 2002, 76:895-904.
- [9]Balachandran S, Barber GN: Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 2004, 5:51-65.
- [10]Stojdl DF, Lichty BD, enOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC: VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003, 4:263-275.
- [11]Suerth JD, Maetzig T, Galla M, Baum C, Schambach A: Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol 2010, 84:6626-6635.
- [12]Santiago A, Godsey AC, Hossain J, Zhao LY, Liao D: Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions. Cell Cycle 2009, 8:76-87.
- [13]Roberts RM, Liu L, Guo Q, Leaman D, Bixby J: The evolution of the type I interferons. J Interferon Cytokine Res 1998, 18:805-816.
- [14]Crawford NG, Faircloth BC, McCormack JE, Brumfield RT, Winker K, Glenn TC: More than 1000 ultraconserved elements provide evidence that turtles are the sister group of archosaurs. Biol Lett 2012, 8:783-786.
- [15]Schreiner S, Wodrich H: Virion factors that target Daxx to overcome intrinsic immunity. J Virol 2013, 87:10412-10422.
- [16]Malim MH, Bieniasz PD: HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med 2012, 2:a006940.
- [17]Hattlmann CJ, Kelly JN, Barr SD: TRIM22: a diverse and dynamic antiviral protein. Mol Biol Int 2012, 2012:153415.
- [18]Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C: The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013, 14:398-410.